07/26/2026
"Abstract: Background: Transcranial magnetic stimulation (TMS) is a noninvasive brain stimulation technique that may potentially be helpful for neuropsychiatric symptoms of developmental disorders with inflammatory aspects. TMS utilizes a varying magnetic field to induce electrical changes in the brain. Repetitive use of TMS modulates plasticity at multiple levels, particularly at the synapse and network level. Summary: As inflammation can affect synaptic plasticity negatively, TMS may theoretically be a tool to address this inflammation-induced dysfunction. There are also data to suggest that TMS can directly downregulate inflammation. Neuropsychiatric consequences of multiple disorders with inflammatory aspects, particularly neurodevelopmental disorders like autism, Tourette syndrome, and obsessive-compulsive disorder (OCD), may be treated effectively with TMS. Treatment of OCD, treatment-resistant major depression, and ni****ne cessation (all in adults) are currently FDA-cleared indications, while migraine is cleared for ages 12 and above. Key Messages: TMS will likely continue to grow in terms of indications as research continues to assess what brain networks are dysfunctional in various disorders, and it becomes clearer how to modulate these networks. TMS may thus be best understood as a technology platform that can be utilized to modulate different brain networks affected in neuropsychiatric disorders. TMS is likely to become an increasingly important tool in targeting brain networks that could become dysfunctional in part due to inflammation in the developing brain and addressing consequent neuropsychiatric symptoms." Access the full article here: https://karger.com/dne/article/45/6/342/869703/Transcranial-Magnetic-Stimulation-for
